Showing results (41-50 of 107) with videos related to
Sort By:
Pageof 11
Frontiers in Pharmacology|October 17, 2022
Identifying optimal PD-1/PD-L1 inhibitors in first-line treatment of patients with advanced squamous non-small cell lung cancer in China: Updated systematic review and network meta-analysisMingye Zhao, Taihang Shao, Yinan Ren, et al.BMC Public Health|August 11, 2023
Cost-effectiveness and potential budget impact of non-pharmacological interventions for early management in prehypertensive people: an economic evaluation for ChinaLeyi Liang, Taihang Shao, Hao Li, et al.The Science of the Total Environment|October 28, 2022
Evolution and improvement options of ecological environmental quality in the world's largest emerging urban green heart as revealed by a new assessment frameworkWenxi Tang, Shuguang Liu, Shuailong Feng, et al.Cost Effectiveness and Resource Allocation : C/E|February 6, 2024
Is it time for China to prioritize pan-genotypic regimens for treating patients with hepatitis C?Yusi Tu, Xiangyan Tang, Dachuang Zhou, et al.Frontiers in Public Health|October 16, 2023
Cost-effectiveness analysis of atezolizumab in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen: a United Kingdom health care perspectiveYunlin Jiang, Mingye Zhao, Jiayi Xi, et al.BMC Health Services Research|November 30, 2016
Effect of continuity of care on health-related quality of life in adult patients with hypertension: a cohort study in ChinaTing Ye, Xiaowei Sun, Wenxi Tang, et al.International Journal of Integrated Care|July 3, 2014
Integrated care: a comprehensive bibliometric analysis and literature reviewXiaowei Sun, Wenxi Tang, Ting Ye, et al.Scientific Reports|July 6, 2026
Physical activity and fruit and vegetable intake among Chinese college students through psychological pathwaysJiaofeng Liu, Kaimin Chen, Li Yi, et al.JAMA Network Open|May 27, 2025
Adverse Event Costs and Cost-Effectiveness Analyses of Anticancer Drugs: A Systematic ReviewMingye Zhao, Taihang Shao, Yue Yin, et al.Journal of Medical Economics|November 16, 2017
Effects on the medical revenue of comprehensive pricing reform in Chinese urban public hospitals after removing drug markups: case of NanjingWenxi Tang, Jing Xie, Yijuan Lu, et al.Pageof 11